1. Department of Pharmacology and Physiology, College of Medicine, Drexel University, Philadelphia, PA 19102, USA
2. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
3. Charles R. Drew University of Medicine and Science, College of Medicine, Los Angeles, CA 90059, USA
4. Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131, USA
5. Global Neurosciences Institute; Pennington, NJ 08534, USA
Corresponding author:
isaiahhoffman@cdrewu.edu
Show less
History+
Received
Accepted
Published Online
2025-09-19
2026-02-28
2026-06-12
PDF
(653KB)
Abstract
The locus coeruleus (LC), a cluster of noradrenergic neurons in the dorsal pons, is the brain’s main source of norepinephrine (NE), crucial for memory, cognition, and stress response. NE dysregulation has been linked to mood disorders, chronic stress, and neurodegenerative diseases like Alzheimer’s disease (AD). Amyloid-β42 (Aβ42) is a key protein in AD pathology, forms plaques that trigger neurodegeneration. Studies show elevated Aβ42 levels are associated with anxiety symptoms, even in cognitively normal individuals. Previous research suggests a positive correlation between NE and Aβ42, with Aβ42 present in NE-producing LC neurons. NE may affect Aβ42 levels through adrenergic receptors on neurons or microglia. However, the exact role of NE in modulating Aβ42 remains unclear. Using the NE depletion models, N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP-4) lesions and dopamine β-hydroxylase (DBH) knockout (KO) mice, researchers found reduced Aβ42 levels without changes in amyloid precursor protein processing. A newer model, dopamine β-hydroxylase internal ribosome entry site-Cre × floxed tyrosine hydroxylase (DBH-IRES-Cre × floxed-TH) preserved dopamine (DA) but eliminated NE in adrenergic neurons, further supporting NE’s specific influence on Aβ42. Findings indicate that decreased Aβ42 in NE-depleted mice stems not from altered DA but from NE loss. This highlights the NE-mediated regulation of endogenous Aβ42 and NE’s role in AD-related pathology.
Isaiah Hoffman, Jennifer A. Ross, Marissa Tumasz, Steven A. Thomas, Elisabeth J. Van Bockstaele.
Norepinephrine-mediated regulation of endogenous Aβ42 peptide levels: effects of noradrenergic depletion and restoration.
MedScience DOI:10.1007/s11684-026-1242-y
This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.